Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Avonex was produced by Biogen Idec.

PMEA 2006: Winners in pictures

Avonex: How clear thinking and teamwork dramatically turned around the fortunes of a mature brand.

IPA Best of Health Awards

entry. agency. silver. Avonex - Shoe Box. Seven Stones. Idrolax - The Required Effect.

Biogen Q3 FY07 net profit falls nearly a quarter

MS drugs disappoint. Sales for Avonex (interferon beta-1a) increased 2.2 per cent to reach USD 454.9m.

Teva begins second Phase III trial of oral MS treatment

It will evaluate the safety, tolerability and effectiveness of laquinimod and produce risk-benefit data for laquinimod versus Avonex, an injectable treatment.

Multiple targets

Current treatments. Six MS disease-modifying drugs have been launched in the US and Europe since 1993: Avonex, Betaseron, Rebif, Copaxone, Novantrone and Tysabri.

[ Previous 5 results ] 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK
This report reveals insights from the people themselves, and discusses the starting points for overcoming current challenges....
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative...
OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...